Further driving factors of transcription (including the activator protein 1 (AP1) family member JunB) are suggested as being upstream regulators and are associated with hypo-methylated CpG sites (hypomethylated in ALCL as compared to normal CD3 T cells). The gene discussed is JUND; the disease is anaplastic large cell lymphoma.